191 related articles for article (PubMed ID: 17622129)
21. The antagonism between apigenin and protoapigenone to the PDK-1 target in Macrothelypteris torresiana.
Liu Z; Cao S; Jin C; He Y; Zhou X; Zhang H; Liu Z
Fitoterapia; 2019 Apr; 134():14-22. PubMed ID: 30731149
[TBL] [Abstract][Full Text] [Related]
22. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
23. Novel flavonoids with antiproliferative activities against breast cancer cells.
Yao N; Chen CY; Wu CY; Motonishi K; Kung HJ; Lam KS
J Med Chem; 2011 Jul; 54(13):4339-49. PubMed ID: 21599001
[TBL] [Abstract][Full Text] [Related]
24. Fern plant-derived protoapigenone leads to DNA damage, apoptosis, and G(2)/m arrest in lung cancer cell line H1299.
Chiu CC; Chang HW; Chuang DW; Chang FR; Chang YC; Cheng YS; Tsai MT; Chen WY; Lee SS; Wang CK; Chen JY; Wang HM; Chen CC; Liu YC; Wu YC
DNA Cell Biol; 2009 Oct; 28(10):501-6. PubMed ID: 19630532
[TBL] [Abstract][Full Text] [Related]
25. Synthetic flavonols and flavones: A future perspective as anticancer agents.
Shoaib M; Ghias M; Shah SWA; Ali N; Umar MN; - A; Rahman M; - S
Pak J Pharm Sci; 2019 May; 32(3):1081-1089. PubMed ID: 31278723
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.
Wang CH; Wu HT; Cheng HM; Yen TJ; Lu IH; Chang HC; Jao SC; Shing TK; Li WS
J Med Chem; 2011 Dec; 54(24):8574-81. PubMed ID: 22085405
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity.
Huang XH; Xiong PC; Xiong CM; Cai YL; Wei AH; Wang JP; Liang XF; Ruan JL
Phytomedicine; 2010 Oct; 17(12):930-4. PubMed ID: 20381325
[TBL] [Abstract][Full Text] [Related]
28. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones.
Dimmock JR; Kandepu NM; Nazarali AJ; Kowalchuk TP; Motaganahalli N; Quail JW; Mykytiuk PA; Audette GF; Prasad L; Perjési P; Allen TM; Santos CL; Szydlowski J; De Clercq E; Balzarini J
J Med Chem; 1999 Apr; 42(8):1358-66. PubMed ID: 10212121
[TBL] [Abstract][Full Text] [Related]
29. Sequential cytotoxicity: a theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones and related compounds.
Dimmock JR; Kandepu NM; Nazarali AJ; Motaganahalli NL; Kowalchuk TP; Pugazhenthi U; Prisciak JS; Quail JW; Allen TM; LeClerc R; Santos CL; De Clercq E; Balzarini J
J Med Chem; 2000 Oct; 43(21):3933-40. PubMed ID: 11052798
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anticancer effect of B-ring trifluoromethylated flavonoids.
Zheng X; Cao JG; Meng WD; Qing FL
Bioorg Med Chem Lett; 2003 Oct; 13(20):3423-7. PubMed ID: 14505641
[TBL] [Abstract][Full Text] [Related]
31. Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues.
Nakagawa-Goto K; Chang PC; Lai CY; Hung HY; Chen TH; Wu PC; Zhu H; Sedykh A; Bastow KF; Lee KH
J Med Chem; 2010 Sep; 53(18):6699-705. PubMed ID: 20735140
[TBL] [Abstract][Full Text] [Related]
32. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.
Dankó B; Tóth S; Martins A; Vágvölgyi M; Kúsz N; Molnár J; Chang FR; Wu YC; Szakács G; Hunyadi A
ChemMedChem; 2017 Jun; 12(11):850-859. PubMed ID: 28436164
[TBL] [Abstract][Full Text] [Related]
34. 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines.
Wells G; Berry JM; Bradshaw TD; Burger AM; Seaton A; Wang B; Westwell AD; Stevens MF
J Med Chem; 2003 Feb; 46(4):532-41. PubMed ID: 12570375
[TBL] [Abstract][Full Text] [Related]
35. Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
Daskiewicz JB; Depeint F; Viornery L; Bayet C; Comte-Sarrazin G; Comte G; Gee JM; Johnson IT; Ndjoko K; Hostettmann K; Barron D
J Med Chem; 2005 Apr; 48(8):2790-804. PubMed ID: 15828817
[TBL] [Abstract][Full Text] [Related]
36. Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones.
Quintin J; Buisson D; Thoret S; Cresteil T; Lewin G
Bioorg Med Chem Lett; 2009 Jul; 19(13):3502-6. PubMed ID: 19457664
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents.
Wu T; Li T; Kang YN; Liu L; Wang XM; Lan JS; Ding Y; Zhang T
Molecules; 2018 Aug; 23(9):. PubMed ID: 30150543
[TBL] [Abstract][Full Text] [Related]
38. New cytotoxic flavonoids from Thelypteris torresiana.
Lin AS; Chang FR; Wu CC; Liaw CC; Wu YC
Planta Med; 2005 Sep; 71(9):867-70. PubMed ID: 16206043
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
40. Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Csekes E; Vágvölgyi M; Hunyadi A; Račková L
Life Sci; 2020 Nov; 260():118419. PubMed ID: 32931795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
